| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC3 ABCA2 CEACAM5 PSG3 PSG11 NPC1L1 STRA6 ATP10A ATP8B2 CEACAM1 | 1.09e-08 | 196 | 85 | 10 | GO:0005319 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.36e-07 | 29 | 85 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.96e-07 | 14 | 85 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.13e-07 | 34 | 85 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.25e-07 | 70 | 85 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.74e-07 | 73 | 85 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.55e-06 | 23 | 85 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 6.70e-06 | 29 | 85 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | floppase activity | 4.01e-05 | 16 | 85 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.11e-05 | 90 | 85 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | glycolipid binding | 5.60e-05 | 49 | 85 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | transporter activity | ABCC3 CACNA2D4 ABCA2 CEACAM5 PSG3 PSG11 NPC1L1 SLC28A1 STRA6 PKD1L2 PKD1L3 SLC22A24 ATP10A TAP2 ATP8B2 CEACAM1 | 9.43e-05 | 1289 | 85 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 9.63e-05 | 173 | 85 | 6 | GO:0070851 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.26e-04 | 28 | 85 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 2.66e-04 | 6 | 85 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 4.39e-04 | 149 | 85 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 4.93e-04 | 8 | 85 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 5.21e-04 | 37 | 85 | 3 | GO:0061631 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 7.88e-04 | 10 | 85 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 8.12e-04 | 43 | 85 | 3 | GO:0061650 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.19e-03 | 49 | 85 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.34e-03 | 51 | 85 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC3 CACNA2D4 ABCA2 CEACAM5 PSG3 PSG11 SLC28A1 STRA6 PKD1L2 PKD1L3 SLC22A24 TAP2 CEACAM1 | 1.40e-03 | 1180 | 85 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 1.58e-03 | 14 | 85 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.91e-03 | 207 | 85 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.95e-03 | 208 | 85 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.04e-03 | 210 | 85 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.09e-03 | 310 | 85 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | flippase activity | 2.34e-03 | 17 | 85 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.74e-03 | 441 | 85 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.02e-03 | 230 | 85 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 3.24e-03 | 20 | 85 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 3.24e-03 | 20 | 85 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.34e-03 | 144 | 85 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.60e-03 | 614 | 85 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 5.04e-03 | 25 | 85 | 2 | GO:0070034 | |
| GeneOntologyMolecularFunction | opsonin binding | 5.04e-03 | 25 | 85 | 2 | GO:0001846 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.55e-08 | 23 | 86 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.47e-08 | 24 | 86 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.47e-08 | 24 | 86 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.57e-08 | 25 | 86 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.75e-07 | 31 | 86 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.73e-07 | 14 | 86 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.71e-07 | 15 | 86 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.71e-07 | 15 | 86 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.71e-07 | 15 | 86 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.71e-07 | 15 | 86 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.93e-07 | 16 | 86 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.77e-07 | 39 | 86 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.43e-07 | 17 | 86 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.43e-07 | 17 | 86 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.43e-07 | 17 | 86 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 6.57e-07 | 40 | 86 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 7.46e-07 | 41 | 86 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 7.62e-07 | 76 | 86 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.24e-07 | 18 | 86 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.03e-06 | 80 | 86 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.30e-06 | 20 | 86 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.50e-06 | 47 | 86 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.50e-06 | 47 | 86 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.60e-06 | 21 | 86 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.60e-06 | 21 | 86 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.60e-06 | 21 | 86 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.85e-06 | 49 | 86 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.95e-06 | 22 | 86 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.05e-06 | 50 | 86 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.21e-06 | 91 | 86 | 6 | GO:0051055 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.35e-06 | 23 | 86 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.50e-06 | 52 | 86 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.81e-06 | 24 | 86 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.33e-06 | 25 | 86 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 3.62e-06 | 56 | 86 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCC3 ABCA2 CEACAM5 MOSPD2 PSG3 PSG11 NPC1L1 STRA6 SLC22A24 ATP10A ATP8B2 CEACAM1 | 3.84e-06 | 565 | 86 | 12 | GO:0010876 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.59e-06 | 27 | 86 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.09e-06 | 105 | 86 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 5.11e-06 | 60 | 86 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.34e-06 | 28 | 86 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.18e-06 | 29 | 86 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 6.32e-06 | 109 | 86 | 6 | GO:0002228 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCC3 ABCA2 CEACAM5 PSG3 PSG11 NPC1L1 STRA6 SLC22A24 ATP10A ATP8B2 CEACAM1 | 8.09e-06 | 506 | 86 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 8.20e-06 | 66 | 86 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | detection of stimulus | NR2F6 OR11L1 CACNA2D4 TLR2 CRTAM OR2W5P GPR52 C4B TLR9 PKD1L2 PKD1L3 PPEF1 WDR47 | 8.79e-06 | 722 | 86 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 8.83e-06 | 67 | 86 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 9.27e-06 | 32 | 86 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 9.27e-06 | 32 | 86 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 9.27e-06 | 32 | 86 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.02e-05 | 69 | 86 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.05e-05 | 33 | 86 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.05e-05 | 33 | 86 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.10e-05 | 70 | 86 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.17e-05 | 71 | 86 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.19e-05 | 34 | 86 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.19e-05 | 34 | 86 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.26e-05 | 72 | 86 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.33e-05 | 124 | 86 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.34e-05 | 35 | 86 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.35e-05 | 73 | 86 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | ABCC3 ABCA2 CEACAM5 PSG3 PSG11 NPC1L1 STRA6 SLC22A24 CEACAM1 | 1.83e-05 | 358 | 86 | 9 | GO:0015850 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.87e-05 | 38 | 86 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | protein K27-linked ubiquitination | 2.46e-05 | 14 | 86 | 3 | GO:0044314 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.52e-05 | 83 | 86 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.79e-05 | 42 | 86 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 3.22e-05 | 145 | 86 | 6 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.48e-05 | 147 | 86 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.68e-05 | 45 | 86 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | detection of molecule of bacterial origin | 3.77e-05 | 16 | 86 | 3 | GO:0032490 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.93e-05 | 91 | 86 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.02e-05 | 46 | 86 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.02e-05 | 46 | 86 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | detection of biotic stimulus | 4.02e-05 | 46 | 86 | 4 | GO:0009595 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.36e-05 | 93 | 86 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 4.38e-05 | 47 | 86 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 4.46e-05 | 309 | 86 | 8 | GO:0002703 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 5.08e-05 | 96 | 86 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 5.08e-05 | 96 | 86 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 5.17e-05 | 49 | 86 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 5.61e-05 | 98 | 86 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 7.06e-05 | 53 | 86 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 8.53e-05 | 107 | 86 | 5 | GO:0042130 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 8.62e-05 | 173 | 86 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 9.18e-05 | 175 | 86 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.08e-04 | 59 | 86 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.15e-04 | 60 | 86 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 1.15e-04 | 114 | 86 | 5 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.18e-04 | 264 | 86 | 7 | GO:0050866 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.23e-04 | 61 | 86 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 1.31e-04 | 571 | 86 | 10 | GO:0043410 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 1.32e-04 | 187 | 86 | 6 | GO:0001909 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 1.41e-04 | 576 | 86 | 10 | GO:0002443 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.71e-04 | 124 | 86 | 5 | GO:0050672 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.84e-04 | 126 | 86 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.84e-04 | 126 | 86 | 5 | GO:0032945 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 1.98e-04 | 128 | 86 | 5 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 2.04e-04 | 385 | 86 | 8 | GO:0070372 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.06e-04 | 129 | 86 | 5 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.09e-04 | 70 | 86 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.21e-04 | 71 | 86 | 4 | GO:0043114 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.46e-07 | 16 | 85 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | apical part of cell | KL CEACAM5 FN1 PSG3 DYNC2H1 PSG11 NPC1L1 SLC28A1 TLR9 ENPEP CEACAM1 | 2.74e-05 | 592 | 85 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | 2.82e-05 | 487 | 85 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | ciliary membrane | 4.98e-05 | 98 | 85 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.28e-04 | 320 | 85 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.68e-04 | 431 | 85 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 4.32e-04 | 335 | 85 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | symbiont cell surface | 4.50e-04 | 8 | 85 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.99e-04 | 90 | 85 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | specific granule membrane | 5.20e-04 | 91 | 85 | 4 | GO:0035579 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 5.60e-04 | 350 | 85 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | other organism part | 5.77e-04 | 9 | 85 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | receptor complex | 5.86e-04 | 581 | 85 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.99e-04 | 354 | 85 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | protein kinase complex | 6.51e-04 | 170 | 85 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | basal part of cell | 8.80e-04 | 378 | 85 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.44e-03 | 14 | 85 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | blood microparticle | 2.84e-03 | 144 | 85 | 4 | GO:0072562 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 3.87e-03 | 157 | 85 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | specific granule | 4.14e-03 | 160 | 85 | 4 | GO:0042581 | |
| GeneOntologyCellularComponent | T cell receptor complex | 4.42e-03 | 163 | 85 | 4 | GO:0042101 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 4.57e-03 | 785 | 85 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 4.61e-03 | 25 | 85 | 2 | GO:0005697 | |
| GeneOntologyCellularComponent | brush border membrane | 4.72e-03 | 83 | 85 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | endocytic vesicle | 4.78e-03 | 384 | 85 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | cell surface | NLGN3 CEACAM5 PSG3 PSG11 TLR2 CEACAM3 IL17RC PKD1L3 ENPEP CEACAM1 GP5 | 5.27e-03 | 1111 | 85 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | transferase complex | CEACAM5 UBE2D2 UBE2D3 PELP1 PSG3 PIK3C2G PSG11 POLR2A INSRR CEACAM1 | 5.63e-03 | 963 | 85 | 10 | GO:1990234 |
| MousePheno | decreased susceptibility to Coronaviridae infection | 5.66e-09 | 28 | 73 | 6 | MP:0020950 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.93e-07 | 49 | 73 | 6 | MP:0020948 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.55e-06 | 17 | 73 | 4 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.83e-06 | 21 | 73 | 4 | MP:0031415 | |
| MousePheno | decreased susceptibility to viral infection | 3.86e-06 | 125 | 73 | 7 | MP:0002410 | |
| MousePheno | decreased susceptibility to Riboviria infection | 4.21e-06 | 82 | 73 | 6 | MP:0020914 | |
| MousePheno | decreased fatty acid oxidation | 6.72e-06 | 24 | 73 | 4 | MP:0014172 | |
| MousePheno | abnormal fatty acid oxidation | 8.76e-06 | 54 | 73 | 5 | MP:0010953 | |
| MousePheno | increased abdominal fat pad weight | 1.10e-05 | 27 | 73 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.48e-05 | 60 | 73 | 5 | MP:0009790 | |
| MousePheno | abnormal cellular glucose uptake | 1.49e-05 | 102 | 73 | 6 | MP:0003925 | |
| MousePheno | abnormal lipid oxidation | 1.60e-05 | 61 | 73 | 5 | MP:0010951 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.94e-05 | 31 | 73 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.94e-05 | 31 | 73 | 4 | MP:0008964 | |
| MousePheno | increased insulin secretion | 2.03e-05 | 64 | 73 | 5 | MP:0003058 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.17e-05 | 35 | 73 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 3.55e-05 | 36 | 73 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 4.90e-05 | 39 | 73 | 4 | MP:0030022 | |
| MousePheno | decreased susceptibility to infection | 5.30e-05 | 255 | 73 | 8 | MP:0002409 | |
| MousePheno | polyphagia | 5.99e-05 | 80 | 73 | 5 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 7.93e-05 | 44 | 73 | 4 | MP:0031023 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 9.96e-05 | 279 | 73 | 8 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 9.96e-05 | 279 | 73 | 8 | MP:0020185 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.03e-04 | 47 | 73 | 4 | MP:0031617 | |
| MousePheno | abnormal intestine morphology | KL CEACAM5 MAN2C1 PSG3 PSG11 TLR2 LAMA5 C4A C4B FREM1 CEACAM1 | 1.15e-04 | 546 | 73 | 11 | MP:0000477 |
| MousePheno | decreased cellular glucose uptake | 1.65e-04 | 53 | 73 | 4 | MP:0003926 | |
| MousePheno | abnormal insulin secretion | 2.65e-04 | 171 | 73 | 6 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 3.10e-04 | 176 | 73 | 6 | MP:0014195 | |
| MousePheno | abnormal pancreas secretion | 3.82e-04 | 183 | 73 | 6 | MP:0002694 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.04e-04 | 120 | 73 | 5 | MP:0009786 | |
| MousePheno | abnormal muscle cell glucose uptake | 4.09e-04 | 67 | 73 | 4 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 4.09e-04 | 67 | 73 | 4 | MP:0008962 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 4.16e-04 | 186 | 73 | 6 | MP:0020912 | |
| MousePheno | increased food intake | 4.53e-04 | 189 | 73 | 6 | MP:0011939 | |
| MousePheno | abnormal pancreatic beta cell physiology | 5.49e-04 | 196 | 73 | 6 | MP:0003562 | |
| MousePheno | abnormal vascular wound healing | 5.67e-04 | 73 | 73 | 4 | MP:0004883 | |
| MousePheno | abnormal endocrine pancreas physiology | 6.44e-04 | 202 | 73 | 6 | MP:0010147 | |
| MousePheno | decreased oxygen consumption | 7.65e-04 | 79 | 73 | 4 | MP:0005290 | |
| MousePheno | abnormal glycogen homeostasis | 9.26e-04 | 144 | 73 | 5 | MP:0005438 | |
| MousePheno | abnormal blood vessel physiology | 1.01e-03 | 394 | 73 | 8 | MP:0000249 | |
| Domain | ARM-type_fold | 1.82e-04 | 339 | 87 | 8 | IPR016024 | |
| Domain | Anaphylatoxin_comp_syst | 2.13e-04 | 5 | 87 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.13e-04 | 5 | 87 | 2 | IPR001840 | |
| Domain | V-set | 2.20e-04 | 184 | 87 | 6 | PF07686 | |
| Domain | Ig_V-set | 3.35e-04 | 199 | 87 | 6 | IPR013106 | |
| Domain | LRR | 3.53e-04 | 201 | 87 | 6 | PS51450 | |
| Domain | Ig_2 | 3.74e-04 | 73 | 87 | 4 | PF13895 | |
| Domain | LRRCT | 4.39e-04 | 32 | 87 | 3 | PF01463 | |
| Domain | ANATO | 4.44e-04 | 7 | 87 | 2 | SM00104 | |
| Domain | ANATO | 4.44e-04 | 7 | 87 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 4.44e-04 | 7 | 87 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 4.44e-04 | 7 | 87 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 4.44e-04 | 7 | 87 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 5.90e-04 | 8 | 87 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 5.90e-04 | 8 | 87 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 5.90e-04 | 8 | 87 | 2 | IPR019742 | |
| Domain | UQ_con | 7.90e-04 | 39 | 87 | 3 | PF00179 | |
| Domain | Cys-rich_flank_reg_C | 8.27e-04 | 90 | 87 | 4 | IPR000483 | |
| Domain | LRRCT | 8.27e-04 | 90 | 87 | 4 | SM00082 | |
| Domain | L_dom-like | 8.49e-04 | 328 | 87 | 7 | IPR032675 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 8.52e-04 | 40 | 87 | 3 | PS00183 | |
| Domain | UBQ-conjugat_E2 | 9.16e-04 | 41 | 87 | 3 | IPR000608 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 9.16e-04 | 41 | 87 | 3 | PS50127 | |
| Domain | A2M_N | 9.42e-04 | 10 | 87 | 2 | PF01835 | |
| Domain | A2M_N | 9.42e-04 | 10 | 87 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 9.42e-04 | 10 | 87 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 9.42e-04 | 10 | 87 | 2 | PS00477 | |
| Domain | A2M | 9.42e-04 | 10 | 87 | 2 | PF00207 | |
| Domain | A2M_N_2 | 9.42e-04 | 10 | 87 | 2 | IPR011625 | |
| Domain | A2M_comp | 9.42e-04 | 10 | 87 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 9.42e-04 | 10 | 87 | 2 | PF07703 | |
| Domain | A2M_recep | 9.42e-04 | 10 | 87 | 2 | PF07677 | |
| Domain | A2M_comp | 9.42e-04 | 10 | 87 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 9.42e-04 | 10 | 87 | 2 | IPR001599 | |
| Domain | ABC_transporter_CS | 9.83e-04 | 42 | 87 | 3 | IPR017871 | |
| Domain | PKD_channel | 1.15e-03 | 11 | 87 | 2 | PF08016 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.15e-03 | 11 | 87 | 2 | IPR002011 | |
| Domain | PKD1_2_channel | 1.15e-03 | 11 | 87 | 2 | IPR013122 | |
| Domain | LRR_8 | 1.22e-03 | 171 | 87 | 5 | PF13855 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.37e-03 | 12 | 87 | 2 | PS00239 | |
| Domain | ABC_tran | 1.45e-03 | 48 | 87 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.45e-03 | 48 | 87 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.54e-03 | 49 | 87 | 3 | PS00211 | |
| Domain | Ig-like_fold | CEACAM5 FN1 PSG3 PSG11 NTRK3 CEACAM3 CRTAM INSRR CAMTA2 CEACAM1 | 1.62e-03 | 706 | 87 | 10 | IPR013783 |
| Domain | ABC_transporter-like | 1.63e-03 | 50 | 87 | 3 | IPR003439 | |
| Domain | Leu-rich_rpt | 1.67e-03 | 271 | 87 | 6 | IPR001611 | |
| Domain | - | 1.73e-03 | 51 | 87 | 3 | 3.10.110.10 | |
| Domain | P_typ_ATPase_c | 1.88e-03 | 14 | 87 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.88e-03 | 14 | 87 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.88e-03 | 14 | 87 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.88e-03 | 14 | 87 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.88e-03 | 14 | 87 | 2 | PF16209 | |
| Domain | UBQ-conjugating_enzyme/RWD | 1.93e-03 | 53 | 87 | 3 | IPR016135 | |
| Domain | ig | 1.95e-03 | 190 | 87 | 5 | PF00047 | |
| Domain | Immunoglobulin | 1.95e-03 | 190 | 87 | 5 | IPR013151 | |
| Domain | CRAL/TRIO_N_dom | 2.17e-03 | 15 | 87 | 2 | IPR011074 | |
| Domain | C345C | 2.79e-03 | 17 | 87 | 2 | SM00643 | |
| Domain | LH2 | 3.13e-03 | 18 | 87 | 2 | SM00308 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.13e-03 | 18 | 87 | 2 | IPR008930 | |
| Domain | NTR | 3.48e-03 | 19 | 87 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 3.48e-03 | 19 | 87 | 2 | IPR018933 | |
| Domain | IG | 3.50e-03 | 421 | 87 | 7 | SM00409 | |
| Domain | Ig_sub | 3.50e-03 | 421 | 87 | 7 | IPR003599 | |
| Domain | LRR_1 | 3.59e-03 | 219 | 87 | 5 | PF00560 | |
| Domain | - | 3.70e-03 | 663 | 87 | 9 | 2.60.40.10 | |
| Domain | - | 3.87e-03 | 321 | 87 | 6 | 3.80.10.10 | |
| Domain | PLAT | 4.25e-03 | 21 | 87 | 2 | PS50095 | |
| Domain | - | 4.25e-03 | 21 | 87 | 2 | 2.60.60.20 | |
| Domain | CRAL_TRIO | 4.25e-03 | 21 | 87 | 2 | PF00650 | |
| Domain | PLAT | 4.25e-03 | 21 | 87 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.25e-03 | 21 | 87 | 2 | IPR001024 | |
| Domain | TIR | 4.25e-03 | 21 | 87 | 2 | SM00255 | |
| Domain | AAA+_ATPase | 4.60e-03 | 144 | 87 | 4 | IPR003593 | |
| Domain | AAA | 4.60e-03 | 144 | 87 | 4 | SM00382 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | RAF1 CEACAM5 MOSPD2 UBE2D2 UBE2D3 PSG3 PSG11 UBR4 TLR2 BIRC3 C4A C4B CPN2 TLR9 STK11IP CEACAM1 | 2.68e-05 | 995 | 71 | 16 | MM14661 |
| Pubmed | 2.72e-10 | 15 | 88 | 5 | 25490771 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.69e-08 | 13 | 88 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.69e-08 | 13 | 88 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.69e-08 | 13 | 88 | 4 | 16638824 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 20044046 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 32150576 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 6265583 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.69e-08 | 13 | 88 | 4 | 12832451 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.69e-08 | 13 | 88 | 4 | 21670291 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 22162753 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 2702644 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 8380065 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 1279194 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 25724769 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.69e-08 | 13 | 88 | 4 | 22092845 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 11801635 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.69e-08 | 13 | 88 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.69e-08 | 13 | 88 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.69e-08 | 13 | 88 | 4 | 23800882 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 19285068 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 21760897 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.69e-08 | 13 | 88 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.69e-08 | 13 | 88 | 4 | 39168268 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 8402684 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 16619040 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.69e-08 | 13 | 88 | 4 | 8209741 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.69e-08 | 13 | 88 | 4 | 21949477 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 26219866 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 2133556 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 32521208 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 19406938 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.69e-08 | 13 | 88 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.69e-08 | 13 | 88 | 4 | 19358828 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 16680193 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.69e-08 | 13 | 88 | 4 | 34058224 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 10964771 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 32169849 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.69e-08 | 13 | 88 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.69e-08 | 13 | 88 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.69e-08 | 13 | 88 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.69e-08 | 13 | 88 | 4 | 23935487 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 15331748 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.69e-08 | 13 | 88 | 4 | 22406619 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.69e-08 | 13 | 88 | 4 | 25972571 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 19008452 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.69e-08 | 13 | 88 | 4 | 15220458 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 18843289 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 15207636 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 21081647 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 11133662 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 11483763 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 2164599 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 29396368 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 18003729 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.69e-08 | 13 | 88 | 4 | 33352461 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 38381498 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 20739537 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.69e-08 | 13 | 88 | 4 | 27695943 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 20404914 | ||
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.69e-08 | 13 | 88 | 4 | 32027621 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.69e-08 | 13 | 88 | 4 | 27777319 | |
| Pubmed | 2.69e-08 | 13 | 88 | 4 | 18848945 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 3.76e-08 | 14 | 88 | 4 | 34666041 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 3.76e-08 | 14 | 88 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 3.76e-08 | 14 | 88 | 4 | 32209360 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 11994468 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 11850617 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 3.76e-08 | 14 | 88 | 4 | 26196244 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 8896983 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 22962327 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 17623671 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 3.76e-08 | 14 | 88 | 4 | 18794798 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 23469261 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 18454175 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 22159884 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 29907459 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 36719377 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 23780386 | ||
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 28567513 | ||
| Interaction | PSG4 interactions | 3.99e-06 | 8 | 85 | 3 | int:PSG4 | |
| Interaction | COLQ interactions | 1.10e-05 | 33 | 85 | 4 | int:COLQ | |
| Cytoband | 19q13.2 | 2.90e-04 | 164 | 88 | 4 | 19q13.2 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.61e-05 | 163 | 65 | 6 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.08e-05 | 394 | 65 | 8 | 471 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 8.50e-05 | 24 | 65 | 3 | 906 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 4.29e-04 | 41 | 65 | 3 | 102 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.29e-04 | 41 | 65 | 3 | 1298 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.51e-04 | 9 | 65 | 2 | 1234 | |
| GeneFamily | CD molecules|Toll like receptors | 5.62e-04 | 10 | 65 | 2 | 948 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 6.85e-04 | 11 | 65 | 2 | 1315 | |
| GeneFamily | ATPase phospholipid transporting | 1.30e-03 | 15 | 65 | 2 | 1210 | |
| GeneFamily | Complement system|Sushi domain containing | 7.41e-03 | 36 | 65 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 7.82e-03 | 37 | 65 | 2 | 454 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 9.09e-03 | 40 | 65 | 2 | 321 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.05e-02 | 43 | 65 | 2 | 409 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.08e-07 | 35 | 87 | 5 | MM757 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 2.43e-06 | 259 | 87 | 8 | M40029 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 3.79e-06 | 32 | 87 | 4 | MM2 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.07e-05 | 87 | 87 | 5 | MM851 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.53e-05 | 159 | 87 | 6 | MM760 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.97e-05 | 48 | 87 | 4 | MM531 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP | 5.53e-05 | 200 | 87 | 6 | M9324 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 5.69e-05 | 201 | 87 | 6 | MM1294 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 5.69e-05 | 201 | 87 | 6 | MM1006 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 8.86e-05 | 135 | 87 | 5 | MM965 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 9.13e-05 | 219 | 87 | 6 | MM3826 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.15e-04 | 75 | 87 | 4 | MM605 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.19e-04 | 230 | 87 | 6 | MM986 | |
| Drug | AC1L1IPV | 6.59e-07 | 43 | 88 | 5 | CID000004683 | |
| Drug | Mas-G | 1.93e-06 | 7 | 88 | 3 | CID000195918 | |
| Drug | KI-8110 | 9.00e-06 | 11 | 88 | 3 | CID003081597 | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A | 1.11e-05 | 196 | 88 | 7 | 1968_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.15e-05 | 197 | 88 | 7 | 4158_DN | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; HL60; HG-U133A | 1.15e-05 | 197 | 88 | 7 | 1600_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.22e-05 | 199 | 88 | 7 | 7367_UP | |
| Drug | Arg-Phe-Asp-Ser | 4.42e-05 | 3 | 88 | 2 | CID005236782 | |
| Drug | 2-aminothiophenol | 4.42e-05 | 3 | 88 | 2 | ctd:C005464 | |
| Drug | Rodorubicine | 4.42e-05 | 3 | 88 | 2 | CID000057097 | |
| Drug | P3cs | 5.17e-05 | 19 | 88 | 3 | CID000126985 | |
| Drug | AC1L2ZKY | 8.82e-05 | 4 | 88 | 2 | CID000131675 | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; PC3; HT_HG-U133A | 9.31e-05 | 189 | 88 | 6 | 4308_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A | 1.07e-04 | 194 | 88 | 6 | 1377_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 6183_UP | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 5447_DN | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 6052_UP | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 2884_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 2906_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.11e-04 | 195 | 88 | 6 | 3800_UP | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 4667_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.14e-04 | 196 | 88 | 6 | 6704_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 4625_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; HL60; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 2181_UP | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 1698_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 3098_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 6509_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 5249_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A | 1.17e-04 | 197 | 88 | 6 | 1842_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 3869_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; HL60; HT_HG-U133A | 1.20e-04 | 198 | 88 | 6 | 2537_UP | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 2165_DN | |
| Drug | Ronidazole [7681-76-7]; Up 200; 20uM; HL60; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 6134_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 4490_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 4526_DN | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; HL60; HT_HG-U133A | 1.24e-04 | 199 | 88 | 6 | 3061_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.27e-04 | 200 | 88 | 6 | 3927_UP | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.27e-04 | 200 | 88 | 6 | 4525_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.27e-04 | 200 | 88 | 6 | 6996_DN | |
| Drug | okadaic acid tetramethyl ether | 1.47e-04 | 5 | 88 | 2 | CID000147507 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 3.15e-05 | 62 | 85 | 4 | DOID:9074 (is_implicated_in) | |
| Disease | pregnanediol-3-glucuronide measurement | 2.27e-04 | 8 | 85 | 2 | EFO_0800341 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 2.44e-04 | 42 | 85 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | end stage renal disease (is_marker_for) | 3.20e-04 | 46 | 85 | 3 | DOID:783 (is_marker_for) | |
| Disease | cutaneous leishmaniasis (is_marker_for) | 3.64e-04 | 10 | 85 | 2 | DOID:9111 (is_marker_for) | |
| Disease | Disorder of eye | 3.76e-04 | 212 | 85 | 5 | C0015397 | |
| Disease | diffuse scleroderma (is_implicated_in) | 4.44e-04 | 11 | 85 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_marker_for) | 5.21e-04 | 128 | 85 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Night blindness, congenital stationary | 1.08e-03 | 17 | 85 | 2 | C0339535 | |
| Disease | allergic rhinitis (is_marker_for) | 1.08e-03 | 17 | 85 | 2 | DOID:4481 (is_marker_for) | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.08e-03 | 17 | 85 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | dermatomyositis (is_marker_for) | 1.08e-03 | 17 | 85 | 2 | DOID:10223 (is_marker_for) | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 1.08e-03 | 17 | 85 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | sinusitis (is_marker_for) | 1.22e-03 | 18 | 85 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | small cell lung carcinoma | 1.62e-03 | 80 | 85 | 3 | EFO_0000702 | |
| Disease | vitiligo (is_implicated_in) | 1.66e-03 | 21 | 85 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.88e-03 | 181 | 85 | 4 | DOID:684 (is_implicated_in) | |
| Disease | apolipoprotein L1 measurement | 2.36e-03 | 25 | 85 | 2 | EFO_0021854 | |
| Disease | acute necrotizing pancreatitis (biomarker_via_orthology) | 2.55e-03 | 26 | 85 | 2 | DOID:0080998 (biomarker_via_orthology) | |
| Disease | anogenital venereal wart (is_marker_for) | 2.55e-03 | 26 | 85 | 2 | DOID:11168 (is_marker_for) | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.75e-03 | 27 | 85 | 2 | DOID:0050861 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WSPALQIRTVLLSIQ | 96 | Q5JXB2 | |
| LSQTLSLVPRLHWLL | 96 | O94766 | |
| LWLQRNAITHLPLSI | 246 | P22792 | |
| RFQILTLWLPDSLTT | 791 | P0C0L5 | |
| QRLLLTASLLTFWNP | 16 | P06731 | |
| ARRFLSLPSTQLDWL | 616 | O94983 | |
| ARLLTFQTWPLTFLS | 171 | Q13489 | |
| PRLSKVNLFTLLSLW | 31 | Q9BWV3 | |
| TLLLWQARLKSNRPS | 381 | Q8TCP9 | |
| LSSLFSLPTFSLLNW | 1426 | O60312 | |
| LQLIPQISSLSWFTT | 86 | P98198 | |
| DWSNIRQLLLFPNST | 186 | P04049 | |
| LPVADQVALLRLSWS | 226 | P10588 | |
| TILRRWTFSQPLEAL | 711 | O75747 | |
| FLNLLWSAPLQIILA | 426 | O15438 | |
| AAVIRNLTALWNPSL | 36 | Q9UH64 | |
| LPITFLRNITWTLSN | 211 | A9QM74 | |
| FPALQTLRNRVWLLS | 806 | Q14667 | |
| LQLSPWESSVVNRLL | 216 | Q14244 | |
| TLSWQLFQTLSLREL | 141 | Q16288 | |
| VWLFSRGALTPLNQL | 561 | A4FU01 | |
| SWLLQDPRLLLRTTN | 176 | Q8NCI6 | |
| NNRLVATWLTLPVAL | 81 | Q6UWP7 | |
| LCFTASIAPQLLWNL | 71 | A6NFC9 | |
| LLLAWASPTFISINR | 16 | Q5H8C1 | |
| RWFLLLALLNSVVNP | 276 | Q9UBY5 | |
| WLNGTVSLPVNLRLL | 771 | Q07075 | |
| LSLSAWSRRANLIIP | 446 | Q9HCN3 | |
| IVARLNLTSPDLFWL | 916 | O15230 | |
| TTVPLLLANLLSWGQ | 76 | Q8NGX0 | |
| NQSLLASSEWPELRL | 1221 | Q9UKK3 | |
| FNPLIRLQLLTWTPL | 626 | Q9Y5B6 | |
| ILIGRLLPQVLNSWS | 396 | Q8IZL8 | |
| RVLDNPTLSFLTTWL | 291 | Q9Y2T5 | |
| LEPTLRSSQLLWEAL | 301 | Q27J81 | |
| LRGFWPRSLTLLQSN | 716 | Q7Z442 | |
| VASQPWNRFLLFTLL | 1146 | Q5TIA1 | |
| LWALLLRLAQSEPYT | 11 | Q9UHC9 | |
| ALNPLRAVWLTLTAA | 11 | Q9H8P0 | |
| LWFLSLALRASTQAP | 26 | Q9NZ94 | |
| LNTLQPKDTFRLWLT | 3796 | Q8NCM8 | |
| LLSVLHRLLLTWNPS | 1641 | Q9P2D3 | |
| HRLLLTWNPSSVQLL | 1646 | Q9P2D3 | |
| ITQILRNPWFSRLDS | 116 | Q8WXQ3 | |
| LSLLAWFPLQEASLT | 6 | O95727 | |
| QGLLLTASLLTFWNP | 16 | P13688 | |
| DSSLIQQVLLRPSFW | 36 | A2CJ06 | |
| RFLATTPNSLLVSWQ | 2001 | P02751 | |
| SPISAFLTATRWLLQ | 956 | Q7Z3S7 | |
| LWRFLTQNLSLPNST | 161 | Q9BZC7 | |
| QGLLLTASLLNFWNP | 16 | P40198 | |
| AWFLLQISPNSRLSQ | 771 | Q9NTJ4 | |
| QSWNLLDVELPLSRT | 541 | P14616 | |
| WLNRTQLRTLPAAAF | 296 | P40197 | |
| SPNLRQLLSWIDLEF | 391 | Q9UEF7 | |
| TALLLNFWNLPTTAQ | 21 | Q9UQ72 | |
| LWTLISPFINENTRR | 431 | O43304 | |
| TSQLLALLAWLRSPR | 121 | Q96AC6 | |
| RFQILTLWLPDSLTT | 791 | P0C0L4 | |
| RLQLLTLQSWLLDAP | 376 | Q8NAC3 | |
| TALLLNFWNLPTTAQ | 21 | Q16557 | |
| LGLNLPWRSLSSNLV | 516 | O14829 | |
| LAAARLLSTWQRLPQ | 491 | Q3MIP1 | |
| SVNDLNESSIPRWLL | 76 | Q8NHP6 | |
| SWLQLTLAVPLQDLS | 851 | Q8N1F8 | |
| LLNFLIWQDALPSSL | 851 | Q6YHU6 | |
| LWALLNLTVALAFNP | 6 | Q8IYP2 | |
| SLWNRLSVLLNLLPA | 681 | Q9UPR3 | |
| NTFILSLEWTLPRSR | 216 | Q8N4F4 | |
| LLATVQLWNLLRHSP | 1561 | Q7Z443 | |
| RFLWSLPQSDLLRGN | 131 | Q9UIU6 | |
| SNWLPLNANVLLRSL | 261 | Q03519 | |
| WLLRDRQSLPASNAF | 16 | Q92781 | |
| RNLLLFRSLESSWPF | 461 | Q9BX79 | |
| SQELFRLLPSELTLW | 91 | P62324 | |
| LDILRSQWSPALTIS | 86 | P62837 | |
| DLSLLSWLQNLPSSV | 241 | O94967 | |
| SLQSLWLLSRFQKPV | 2001 | Q99973 | |
| IWLDLSQNRLHTLLP | 631 | Q9NR96 | |
| TLTTSPWLQLFINAR | 1316 | O15067 | |
| ILPWSTFRLNLSVTT | 476 | P24928 | |
| LDILRSQWSPALTIS | 86 | P61077 | |
| LWLSLDTSQRPEQLV | 166 | O00337 | |
| LRSAQIWSLASPLRS | 161 | P59923 | |
| FSRQCTLLLFLQRPW | 311 | P48553 | |
| PQSLSVLSRLLLIWQ | 751 | Q5T4S7 | |
| SLRLADVLWNSQIPL | 136 | Q13564 | |
| WPSLQTLILRQNHLA | 386 | O60603 | |
| LLFLTLALFLSNPWT | 676 | Q96GX1 | |
| AWLSVPVVLNLLSSR | 376 | Q96S06 | |
| DPLLLLQALQTLWST | 21 | Q8N9H8 |